UCAM and IMIB patent a new use for two drugs to prevent and treat covid-19
Researchers from the two institutions have carried out in-vitro development with Zeaxanthin and Kukoamine A to prevent the virus from entering the cell
Search in:
Researchers from the two institutions have carried out in-vitro development with Zeaxanthin and Kukoamine A to prevent the virus from entering the cell
The groups BIO-HPC and UKEIM of the UCAM obtain two new projects co-financed by the Séneca Foundation.